CGEM
Cullinan Oncology Inc

463
Mkt Cap
$915.68M
Volume
554.00
52W High
$16.74
52W Low
$5.68
PE Ratio
-4.21
CGEM Fundamentals
Price
$15.50
Prev Close
$15.21
Open
$15.17
50D MA
$11.65
Beta
1.13
Avg. Volume
685,600.45
EPS (Annual)
-$3.11
P/B
2.03
Rev/Employee
$0.00
$258.10
Loading...
Loading...

About

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
111

Frequently Asked Questions

What is Market Cap of Cullinan Therapeutics Inc?
What is the 52-week high for Cullinan Therapeutics Inc?
What is the 52-week low for Cullinan Therapeutics Inc?
What is Cullinan Therapeutics Inc stock price today?
What was Cullinan Therapeutics Inc stock price yesterday?
What is the PE ratio of Cullinan Therapeutics Inc?
What is the Price-to-Book ratio of Cullinan Therapeutics Inc?
What is the 50-day moving average of Cullinan Therapeutics Inc?
How many employees does Cullinan Therapeutics Inc have?

Latest CGEM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.